224 related articles for article (PubMed ID: 15734853)
1. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans.
Raju B; Cryer PE
Diabetes; 2005 Mar; 54(3):757-64. PubMed ID: 15734853
[TBL] [Abstract][Full Text] [Related]
2. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
Banarer S; McGregor VP; Cryer PE
Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
[TBL] [Abstract][Full Text] [Related]
3. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.
Gosmanov NR; Szoke E; Israelian Z; Smith T; Cryer PE; Gerich JE; Meyer C
Diabetes Care; 2005 May; 28(5):1124-31. PubMed ID: 15855577
[TBL] [Abstract][Full Text] [Related]
4. Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes.
Israelian Z; Gosmanov NR; Szoke E; Schorr M; Bokhari S; Cryer PE; Gerich JE; Meyer C
Diabetes Care; 2005 Nov; 28(11):2691-6. PubMed ID: 16249541
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.
Bolli G; De Feo P; Perriello G; De Cosmo S; Compagnucci P; Santeusanio F; Brunetti P; Unger RH
J Clin Invest; 1984 Apr; 73(4):917-22. PubMed ID: 6368593
[TBL] [Abstract][Full Text] [Related]
6. The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humans.
Peacey SR; Rostami-Hodjegan A; George E; Tucker GT; Heller SR
J Clin Endocrinol Metab; 1997 May; 82(5):1458-61. PubMed ID: 9141533
[TBL] [Abstract][Full Text] [Related]
7. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.
Sjöberg S; Ahrén B; Bolinder J
J Intern Med; 2002 Oct; 252(4):342-51. PubMed ID: 12366607
[TBL] [Abstract][Full Text] [Related]
8. ATP-sensitive K+ channel mediates the zinc switch-off signal for glucagon response during glucose deprivation.
Slucca M; Harmon JS; Oseid EA; Bryan J; Robertson RP
Diabetes; 2010 Jan; 59(1):128-34. PubMed ID: 19808893
[TBL] [Abstract][Full Text] [Related]
9. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH
J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
[TBL] [Abstract][Full Text] [Related]
10. Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia.
McGregor VP; Banarer S; Cryer PE
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E770-7. PubMed ID: 11882496
[TBL] [Abstract][Full Text] [Related]
11. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
[TBL] [Abstract][Full Text] [Related]
12. Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia.
Degn KB; Brock B; Juhl CB; Djurhuus CB; Grubert J; Kim D; Han J; Taylor K; Fineman M; Schmitz O
Diabetes; 2004 Sep; 53(9):2397-403. PubMed ID: 15331551
[TBL] [Abstract][Full Text] [Related]
13. Serum glucagon counterregulatory hormonal response to hypoglycemia is blunted in congenital hyperinsulinism.
Hussain K; Bryan J; Christesen HT; Brusgaard K; Aguilar-Bryan L
Diabetes; 2005 Oct; 54(10):2946-51. PubMed ID: 16186397
[TBL] [Abstract][Full Text] [Related]
14. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic alpha-cell function in idiopathic reactive hypoglycemia.
Ahmadpour S; Kabadi UM
Metabolism; 1997 Jun; 46(6):639-43. PubMed ID: 9186298
[TBL] [Abstract][Full Text] [Related]
16. Partial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia.
Ramanathan RP; Arbeláez AM; Cryer PE
Diabetes; 2011 Apr; 60(4):1324-8. PubMed ID: 21378174
[TBL] [Abstract][Full Text] [Related]
17. The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined.
Gupta V; Wahoff DC; Rooney DP; Poitout V; Sutherland DE; Kendall DM; Robertson RP
Diabetes; 1997 Jan; 46(1):28-33. PubMed ID: 8971077
[TBL] [Abstract][Full Text] [Related]
18. Glucagon is paradoxically secreted at high concentrations of glucose in rat pancreas perfused with diazoxide.
Mokuda O; Shibata M; Ooka H; Okazaki R; Sakamoto Y
Diabetes Nutr Metab; 2002 Aug; 15(4):260-4. PubMed ID: 12416665
[TBL] [Abstract][Full Text] [Related]
19. Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations.
Guenat E; Seematter G; Philippe J; Temler E; Jequier E; Tappy L
Diabetes Metab; 2000 Nov; 26(5):377-84. PubMed ID: 11119017
[TBL] [Abstract][Full Text] [Related]
20. Autonomic mediation of glucagon secretion during insulin-induced hypoglycemia in rhesus monkeys.
Havel PJ; Valverde C
Diabetes; 1996 Jul; 45(7):960-6. PubMed ID: 8666149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
